Zepp Health Corporation (ZEPP) Earnings History
Annual and quarterly earnings data from 2015 to 2024
Loading earnings history...
ZEPP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ZEPP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 38.5% | -25.9% | -41.6% |
| 2023 | 26.2% | -8.6% | -8.8% |
| 2022 | 19.4% | -9.9% | -7.0% |
| 2021 | 20.9% | 1.5% | 2.2% |
| 2020 | 20.7% | 2.7% | 3.6% |
Download Data
Export ZEPP earnings history in CSV or JSON format
Free sign-in required to download data
Zepp Health Corporation (ZEPP) Earnings Overview
As of May 8, 2026, Zepp Health Corporation (ZEPP) reported trailing twelve-month net income of -$479M, reflecting -1642.9% year-over-year growth. The company earned $-30.29 per diluted share over the past four quarters, with a net profit margin of -41.6%.
Looking at the long-term picture, ZEPP's historical earnings data spans multiple years. The company achieved its highest annual net income of $574M in fiscal 2019.
Zepp Health Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including GRMN ($1.74B net income, 23.0% margin), FOSL (-$78M net income, -7.8% margin), SMPL ($91M net income, 7.1% margin), ZEPP has room to improve margins relative to the peer group. Compare ZEPP vs GRMN →
ZEPP Earnings vs Peers
Earnings metrics vs comparable public companies
ZEPP Historical Earnings Data (2015–2024)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$554M | -151.3% | -$345M | $-34.16 | -41.6% | -25.9% |
| 2023 | -$220M | +24.8% | -$216M | $-1.96 | -8.8% | -8.6% |
| 2022 | -$293M | -315.7% | -$417M | $-2.71 | -7.0% | -9.9% |
| 2021 | $136M | -37.1% | $93M | $1.31 | 2.2% | 1.5% |
| 2020 | $216M | -62.3% | $165M | $2.16 | 3.6% | 2.7% |
| 2019 | $574M | +62.4% | $619M | $35.84 | 9.9% | 10.7% |
| 2018 | $353M | +116.1% | $380M | $8.12 | 9.3% | 10.0% |
| 2017 | $163M | +552.6% | $177M | $0.65 | 8.2% | 8.9% |
| 2016 | $25M | +164.1% | $14M | $-3.52 | 1.5% | 0.9% |
| 2015 | -$39M | - | -$41M | $-19.59 | -4.2% | -4.5% |
See ZEPP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZEPP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZEPP vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonZEPP — Frequently Asked Questions
Quick answers to the most common questions about buying ZEPP stock.
Is ZEPP growing earnings?
ZEPP EPS fell to $-30.29, with earnings declining -1642.9%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-479M.
What are ZEPP's profit margins?
Zepp Health Corporation net margin is -41.6%, with operating margin at -25.9%. Below-average margins reflect competitive or cost pressures.
How consistent are ZEPP's earnings?
ZEPP earnings data spans 2015-2024. The declining earnings trend is -1642.9% YoY. Historical data enables comparison across business cycles.